Established as a partnership in global health, the Global Fund works closely with a wide diversity of partners –implementing governments, donors, civil society, international development organizations, the private sector and communities living with and affected by the diseases. This partnership model actively supports country-owned approaches that develop and implement effective, evidence-based programs to respond to AIDS, tuberculosis and malaria.
The Private Sector Co-payment Mechanism (“Co-payment Mechanism”) is a financing model used by The Global Fund, to expand access to artemisinin-based combination therapies (ACTs), in the private sector. The mechanism is suitable for countries where the private retail sector is a major provider of health technologies for malaria case management. It is possible that over time, the Private Sector Co-payment Mechanism may be expanded to include co-financing of malaria rapid diagnostic tests (RDTs).
The Private Sector Co-payment Mechanism is based on the results of the Independent Evaluation of the Affordable Medicines Facility-malaria (AMFm) Phase 1, which showed that: i) a combination of price negotiations; ii) a subsidy provided directly to manufacturers; and iii) large-scale mass communications; led to rapid and large, changes in price, availability, and market share of quality-assured ACTs.
This video describes the Private Sector Co-payment Mechanism – and explains how eligible countries could apply to participate, via: The Global Fund’s New Funding Model process.
PSM Procurement and Supply Management
P4i Procurement for Impact
Private Sector Co-payment Mechanism
New Funding Model
Contact | Report Fraud and Abuse | Legal | RSS | Sitemap
© 2014 The Global Fund to Fight AIDS, Tuberculosis and Malaria